publication venue for
- The Protease Inhibitor Lopinavir, Boosted with Ritonavir, as Treatment for COVID-19: A Rapid Review. 25:365-376. 2020
- A Comparison of Virological Suppression and Rebound between Indigenous and Non-Indigenous Persons Initiating Combination Antiretroviral Therapy in a Multisite Cohort of Individuals Living with HIV in Canada. 22:325-335. 2017
- Risk of Cardiovascular Disease Associated with HCV and HBV Coinfection among Antiretroviral-Treated HIV-Infected Individuals. 19:309-317. 2014
- CD4+T-cell recovery after initiation of antiretroviral therapy in a resource-limited setting: A prospective cohort analysis. 19:31-39. 2014
- Article Commentary: Long-Term Adherence to Antiretroviral Therapy in Resource-Limited Settings: A Bitter Pill to Swallow. 18:25-28. 2013
- Efficacy of raltegravir and factors associated with treatment failure in a routine clinical care setting: the Swiss HIV Cohort study 2009
- Exercise capacity and markers of mitochondrial function in HIV-infected patients on NRTI therapy 2009
- Antiretroviral exposure and carotid intimal medial thickness in a multicentre Canadian HIV cohort 2004